The following report was received via email from the
VA National Health Physics Program (
NHPP):
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, which holds Permit Number 37-01230-03 under the VA master materials license, reported discovery of a medical event to NHPP at approximately 0730 EDT, May 10, 2021.
An iodine-131 sodium iodide thyroid ablation therapy administration was performed on Friday, May 7, 2021. The prescribed dose was 60 milliCuries but only 31.2 milliCuries were delivered.
The patient and the referring physician have been notified.
NHPP will follow up with a written report in accordance with NRC requirements in 10 CFR 35.3045.
NHPP notified [their] NRC Region III Project Manager, Bryan Parker.
- * * RETRACTION ON 5/20/21 AT 1835 EST FROM EDWIN M. LEIDHOLDT, JR. TO BETHANY CECERE * * *
The following retraction was received via email from the VA National Health Physics Program (NHPP):
A patient at VA Pittsburgh Healthcare System was administered a therapeutic dosage of iodine-131 sodium iodide on May 7, 2021. On May 10, 2021, the facility reported to NHPP that a medical event had occurred. We reported that to NRC Operations Center on May 10, 2021, pursuant to 10 CFR 35.3045. The basis for the medical event was that the facility believed that only a little more than half of the prescribed dosage of 60 milliCuries had been administered to the patient.
Since that time, measurements were made of the material not administered to the patient. These measurements indicate that about 82% of the prescribed activity was administered and therefore a medical event did not occur. Therefore, we wish to retract the report of the medical event.
We have notified Bryan Parker of NRC Region III, NRC project manager for the VA's Master Material License, of our plan to withdraw the event declaration.
Notified R3DO (Cameron) and NMSS Events (by email).
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.